Evidence map›Paper›PMID 39399340›Full record

ArticleJAAD international2024

Prevalence of psychiatric comorbidities and treatment initiation in African American pediatric patients with vitiligo: A retrospective, single-center, case-control study.

Emily Strouphauer, Sana Suhail, Carly Mulinda, Promise Ufomadu, Nicole Nyamongo, Grace Lee, Soo Jung Kim

Abstract read
In one paragraph

Article in JAAD international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emily StrouphauerSchool of Medicine, Baylor College of Medicine, Houston, Texas.
Sana SuhailSchool of Medicine, The University of Texas Health Science Center, San Antonio, Texas.
Carly MulindaColumbia University Vagelos College of Physicians and Surgeons, New York, New York.
Promise UfomaduSchool of Medicine, Baylor College of Medicine, Houston, Texas.
Nicole NyamongoSchool of Medicine, Baylor College of Medicine, Houston, Texas.
Grace LeeDepartments of Dermatology and Pediatrics, Texas Children's Hospital, Houston, Texas.
Soo Jung KimDepartment of Dermatology, Baylor College of Medicine, Houston, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vitiligo may impact psychosocial development, especially among African American pediatric patients, given heightened visibility and increasing rates of anxiety and depression in this subpopulation. Objective: Evaluate psychiatric comorbidities and treatment initiation in African American pediatric patients. Methods: A total of 327 African American pediatric patients with vitiligo were each matched to 3 patients without vitiligo by age, race, and sex in this case-control study. Prevalence of psychiatric conditions and subsequent initiation of pharmacotherapy and/or psychotherapy were analyzed. Results: Compared to controls, pediatric African American patients with vitiligo were significantly more likely to be diagnosed with depression ( Limitations: This retrospective study has a limited sample size in a single institution and does not explore psychiatric treatment efficacy. Conclusions: Better understanding of associated psychological comorbidities and impacts on African American children of vitiligo may improve quality of life and dermatologic outcomes for these individuals.

Indexed as

pediatric dermatologypsychiatric comorbiditiespsychodermatologyskin of colorvitiligo

Identifiers

PMID39399340
PMCPMC11471237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.